Latest News

MEI Pharma to Present at the BTIG Virtual Biotechnology Conference 2020
Helsinn Group and MEI Pharma Discontinue the Phase 3 Study with Pracinostat in AML after Completing Interim Analysis
MEI Pharma to Present at the Jefferies Virtual Healthcare Conference
MEI Pharma to Host Investor and Analyst Video Webcast Following ASCO20 Virtual Scientific Program